Andrew Hopkins, Exscientia CEO

Ex­sci­en­tia spends Soft­Bank's cash in bid to edge out AI ri­vals

Ex­sci­en­tia is sprint­ing to win the great AI biotech race.

The UK com­pa­ny, hav­ing long la­bored on small dis­cov­ery deals with large phar­mas,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA